The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
SNGX · Healthcare · No moat
Doesn't clear the bar
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
DBVT · Healthcare · No moat
Doesn't clear the bar
The pricingPower component abstained: Not enough years of gross-margin data to score pricing power. The other four 20% weights were renormalized over the scored 80%.
| Measure | SNGX | DBVT | ICCC | PGEN |
|---|---|---|---|---|
| Moat Score (0–100) | 33 (highest) | 33 (highest) | 33 (highest) | 33 (highest) |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 27 | 34 | 54 (highest) | 15 |
| Pricing power | 7 | — | 54 | 99 (highest) |
| Returns on capital | — | 0 (highest) | 0 (highest) | 0 (highest) |
| Balance-sheet safety | 55 (highest) | 55 (highest) | 42 | 28 |
| Capital discipline | 44 (highest) | 44 (highest) | 16 | 24 |
| Price vs. high estimate | No price data | No price data | No price data | No price data |
| Market cap | $3.5M | Not reported | $99.5M | $1.8B |
| Moat tier | No moat | No moat | No moat | No moat |
| Filings as of | FY2025 | FY2025 | FY2025 | FY2025 |